Condition: Asthma
Intervention: Other: Observational. Non interventional study
Sponsor: Mundipharma Pharmaceuticals B.V.
Not yet recruiting – verified June 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Skyepharma launches Flutiform in France for asthma – The Pharma Letter
|
Skyepharma launches Flutiform in France for asthma
The Pharma Letter UK drug delivery specialist Skyepharma (LSE: SKP) has received regulatory approval and agreement on pricing reimbursement for asthma treatment Flutiform in France. Skyepharma's licensee Mundipharma, responsible for the development and … Skyepharma Jumps As It Launches Flutiform in France |
View full post on asthma – Google News
BRIEF-SkyePharma launches asthma drug Flutiform in Germany – Reuters
|
BRIEF-SkyePharma launches asthma drug Flutiform in Germany
Reuters Sponsored Links. BRIEF-SkyePharma launches asthma drug Flutiform in Germany. Tweet · Share this · Email · Print. Related Topics. Healthcare ». LONDON, Sept 21 | Fri Sep 21, 2012 5:05am EDT. LONDON, Sept 21 (Reuters) – SkyePharma PLC : * Flutiform … |
View full post on asthma – Google News
New year brings new delay for SkyePharma’s Flutiform asthma inhaler – FierceDrugDelivery
|
New year brings new delay for SkyePharma's Flutiform asthma inhaler
FierceDrugDelivery That's because the British drug delivery company now stands to face an additional delay of between 6 and 9 months in the approval process for its Flutiform asthma therapy. As Reuters and the UK's The Telegraph reported just before the holidays, … |
View full post on asthma – Google News
Skyepharma banking on European approval for Flutiform – Stock Market Wire
|
Skyepharma banking on European approval for Flutiform
Stock Market Wire The group said it was counting on European approval of asthma treatment Flutiform and launch in the second half of 2011. Revenue was up 4% to £58.1m from £55.9m, in line with management expectations. The rise was primarily due to a substantial increase … SkyePharma Moves To 2010 Pretax Profit, Sees Cash Outflows STOCKS NEWS UK-SkyePharma up on results Flutiform optimism Skyepharma turns in annual profit |
View full post on asthma – Google News
Abbott, SkyePharma Part Ways on Asthma Drug Flutiform – BioWorld Online
|
Abbott, SkyePharma Part Ways on Asthma Drug Flutiform
BioWorld Online It was no surprise that the two firms parted ways on the asthma drug candidate after the FDA in January said further clinical trials were needed to file for … |
View full post on asthma – Google News
Kos Pharmaceuticals and SkyePharma terminate license agreement for flutiform – Trading Markets (press release)
|
Kos Pharmaceuticals and SkyePharma terminate license agreement for flutiform
Trading Markets (press release) Flutiform is used for adult and adolescent asthma. Under the terms of the agreement, Kos has the right to perform further clinical development for … Abbott, Skyepharma Part Ways On Asthma Drug Flutiform |
View full post on asthma – Google News
Abbott, Skyepharma Part Ways On Asthma Drug Flutiform – PharmaLive (press release) (subscription)
|
Abbott, Skyepharma Part Ways On Asthma Drug Flutiform
PharmaLive (press release) (subscription) It was no surprise that the two firms parted ways on the asthma drug candidate after the FDA in January said further clinical trials were needed to file for … |
View full post on asthma – Google News